TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+11.16%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$1.09B
AUM Growth
+$1.09B
(+8.9%)
Cap. Flow
+$34M
Cap. Flow
% of AUM
3.12%
Top 10 Holdings %
Top 10 Hldgs %
54.62%
Holding
69
New
7
Increased
13
Reduced
10
Closed
5
Top Buys
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$14.1M |
| 2 |
Incyte
INCY
|
$11.9M |
| 3 |
Pfizer
PFE
|
$9.94M |
| 4 |
Bristol-Myers Squibb
BMY
|
$9.83M |
| 5 |
Neurocrine Biosciences
NBIX
|
$5.38M |
Top Sells
| 1 |
Puma Biotechnology
PBYI
|
$19.4M |
| 2 |
Perrigo
PRGO
|
$15.3M |
| 3 |
AGN
ALLERGAN INC
AGN
|
$10.1M |
| 4 |
iShares Biotechnology ETF
IBB
|
$9.48M |
| 5 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$7.6M |
Sector Composition
| 1 | Healthcare | 88.61% |
| 2 | Financials | 1.84% |
